Goldschmidt H - Search Results

1

Antiangiogenic therapy in hematologic malignancies.

Moehler TM, Hillengass J, Goldschmidt H, Ho AD. Moehler TM, et al. Among authors: goldschmidt h. Curr Pharm Des. 2004;10(11):1221-34. doi: 10.2174/1381612043452587. Curr Pharm Des. 2004. PMID: 15078137 Review.

2

High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.

Neben K, Moehler T, Egerer G, Kraemer A, Hillengass J, Benner A, Ho AD, Goldschmidt H. Neben K, et al. Among authors: goldschmidt h. Clin Cancer Res. 2001 Sep;7(9):2675-81. Clin Cancer Res. 2001. PMID: 11555579 Clinical Trial.

3

Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy.

Moehler TM, Neben K, Benner A, Egerer G, Krasniqi F, Ho AD, Goldschmidt H. Moehler TM, et al. Among authors: goldschmidt h. Blood. 2001 Dec 15;98(13):3846-8. doi: 10.1182/blood.v98.13.3846. Blood. 2001. PMID: 11739195 Free article.

4

Angiogenesis in hematologic malignancies.

Moehler TM, Neben K, Ho AD, Goldschmidt H. Moehler TM, et al. Among authors: goldschmidt h. Ann Hematol. 2001 Dec;80(12):695-705. doi: 10.1007/s00277-001-0398-3. Epub 2001 Nov 14. Ann Hematol. 2001. PMID: 11797109 Review.

5

Angiogenesis in hematologic malignancies.

Moehler TM, Ho AD, Goldschmidt H, Barlogie B. Moehler TM, et al. Among authors: goldschmidt h. Crit Rev Oncol Hematol. 2003 Mar;45(3):227-44. doi: 10.1016/s1040-8428(02)00135-x. Crit Rev Oncol Hematol. 2003. PMID: 12633837 Review.

6

Thalidomide in multiple myeloma.

Moehler TM, Hillengass J, Glasmacher A, Goldschmidt H. Moehler TM, et al. Among authors: goldschmidt h. Curr Pharm Biotechnol. 2006 Dec;7(6):431-40. doi: 10.2174/138920106779116919. Curr Pharm Biotechnol. 2006. PMID: 17168659 Review.

7

[Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma].

Moehler TM, Hawighorst H, Neben K, Egerer G, Benner A, Hillengass J, Max R, Ho AD, Goldschmidt H, van Kaick G. Moehler TM, et al. Among authors: goldschmidt h. Radiologe. 2000 Aug;40(8):723-30. doi: 10.1007/s001170050802. Radiologe. 2000. PMID: 11006943 Clinical Trial. German.

8

Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging.

Moehler TM, Hawighorst H, Neben K, Egerer G, Hillengass J, Max R, Benner A, Ho AD, van Kaick G, Goldschmidt H. Moehler TM, et al. Among authors: goldschmidt h. Int J Cancer. 2001 Sep;93(6):862-8. doi: 10.1002/ijc.1421. Int J Cancer. 2001. PMID: 11519049 Free article.

9

Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion.

Neben K, Moehler T, Kraemer A, Benner A, Egerer G, Ho AD, Goldschmidt H. Neben K, et al. Among authors: goldschmidt h. Br J Haematol. 2001 Dec;115(3):605-8. doi: 10.1046/j.1365-2141.2001.03142.x. Br J Haematol. 2001. PMID: 11736942 Free article. Clinical Trial.

10

[Multiple myeloma. Diagnosis and therapy].

Goldschmidt H, Cremer FW, Möhler TM, Ho AD. Goldschmidt H, et al. Internist (Berl). 2003 May;44(5):599-600, 603-16; quiz 617-8. doi: 10.1007/s00108-003-0920-x. Internist (Berl). 2003. PMID: 12966788 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

814 results

Search Page